![MannKind and One Drop Partner to Launch the A-ONE Clinical Trial](https://www.healthcarenowradio.com/wp-content/uploads/2017/08/onedrop-480-80x80.jpg)
MannKind and One Drop Partner to Launch the A-ONE Clinical Trial
MannKind Corporation and One Drop announced the first step of their collaboration with the launch of the A-ONE study, a randomized controlled trial investigating the use of Afrezza® inhaled insulin and One Drop’s integrated digital diabetes care platform.